Scarica l'app Stockscreener
1.05
0.96%
0.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.04
Aprire:
$1.05
Volume 24 ore:
34,300
Relative Volume:
1.85
Capitalizzazione di mercato:
$12.04M
Reddito:
$996.00K
Utile/perdita netta:
$-6.09M
Rapporto P/E:
-1.9811
EPS:
-0.53
Flusso di cassa netto:
$-9.76M
1 W Prestazione:
-0.94%
1M Prestazione:
-2.78%
6M Prestazione:
+6.06%
1 anno Prestazione:
-33.54%
Intervallo 1D:
$1.0321
$1.06
Intervallo di 1 settimana:
$1.03
$1.09
Portata 52W:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Nome
Therapeuticsmd Inc
Settore
Telefono
561-961-1900
Indirizzo
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Confronta TXMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.0401 | 12.04M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
143.79 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.205 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.77 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.10 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-07 | Downgrade | Jefferies | Hold → Underperform |
| 2020-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Iniziato | Guggenheim | Buy |
| 2019-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-30 | Ripresa | Noble Capital Markets | Outperform |
| 2018-06-15 | Iniziato | JP Morgan | Overweight |
| 2017-09-08 | Iniziato | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Ripresa | Jefferies | Buy |
| 2016-11-22 | Iniziato | Oppenheimer | Outperform |
| 2016-11-07 | Ripresa | Guggenheim | Buy |
| 2016-04-04 | Iniziato | Goldman | Buy |
| 2015-12-08 | Reiterato | Jefferies | Buy |
| 2015-12-08 | Reiterato | Stifel | Buy |
| 2015-09-21 | Reiterato | Jefferies | Buy |
| 2015-06-09 | Iniziato | Guggenheim | Buy |
| 2014-07-08 | Iniziato | FBR Capital | Outperform |
| 2014-04-17 | Reiterato | Noble Financial | Buy |
| 2014-01-28 | Reiterato | Noble Financial | Buy |
Mostra tutto
Therapeuticsmd Inc Borsa (TXMD) Ultime notizie
How to forecast TherapeuticsMD Inc. trends using time seriesMarket Volume Summary & Low Risk Entry Point Guides - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendationDollar Strength & AI Based Buy and Sell Signals - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recoveryQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com
Real time scanner hits for TherapeuticsMD Inc. explainedPortfolio Return Summary & Low Risk Investment Opportunities - newser.com
Comparing TherapeuticsMD Inc. in custom built stock radarsIndex Update & AI Enhanced Trading Alerts - newser.com
Will TherapeuticsMD Inc. price bounce be sustainableJuly 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
Using R and stats models for TherapeuticsMD Inc. forecastingJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
How to read the order book for TherapeuticsMD Inc.Buy Signal & Free Daily Entry Point Trade Alerts - newser.com
Can TherapeuticsMD Inc. stock surprise with earnings upsideJuly 2025 Outlook & Daily Volume Surge Signals - newser.com
TherapeuticsMD Inc. stock prediction for this weekJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Will TherapeuticsMD Inc. stock go up soonJuly 2025 Short Interest & AI Enhanced Trade Execution Alerts - newser.com
How TherapeuticsMD Inc. (29TA) stock reacts to weak economyJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycleEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
Is TherapeuticsMD Inc. stock attractive for hedge fundsJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com
TherapeuticsMD, Inc. (NASDAQ:TXMD) Short Interest Up 93.5% in September - Defense World
What analysts say about TherapeuticsMD Inc stockTrendline Breakouts & Minimal Capital Investment - earlytimes.in
Is TherapeuticsMD Inc. (29TA) stock a good hedge against inflationExit Point & Smart Investment Allocation Insights - newser.com
Published on: 2025-10-05 04:45:14 - newser.com
Forecasting TherapeuticsMD Inc. price range with options dataWeekly Stock Recap & High Yield Equity Trading Tips - newser.com
Real time pattern detection on TherapeuticsMD Inc. stockFed Meeting & Real-Time Volume Analysis Alerts - newser.com
TherapeuticsMD Inc 29TA Stock Analysis and ForecastBearish Engulfing Patterns & Small Investment Growth Plans - earlytimes.in
TherapeuticsMD Inc Stock Analysis and ForecastTrade Execution Strategies & Rapid Capital Appreciation - earlytimes.in
What analysts say about TherapeuticsMD Inc 29TA stockMarket Volatility Update & Interactive Charts for Smarter Trading - earlytimes.in
What drives TherapeuticsMD Inc stock priceRisk Adjusted Returns & Small Budget Wealth Building - earlytimes.in
Is TherapeuticsMD Inc a good long term investmentDividend Yield Trends & Free Expert Guidance For Growth - Early Times
Therapeuticsmd Inc Azioni (TXMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Therapeuticsmd Inc Azioni (TXMD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
0.83%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):